LETTER
Regioselective Cleavage of Terminal Epoxides
1513
Analytical Data of Compounds 3–6
Acknowledgment
Compound 3a: 1H NMR (400 MHz, CDCl3): d = 3.78 (m, 1
H), 3.53 (dd, J = 12.0, 4.0 Hz, 1 H), 3.43–3.36 (m, 3 H), 2.39
(br, 1 H), 1.92–1.82 (m, 2 H), 1.62–1.51 (m, 4 H). 13C NMR
(100 MHz, CDCl3): d = 70.8, 40.3, 34.1, 33.6, 32.4, 24.3. IR
(neat): 3393, 2941, 2864, 1432, 1259, 1050, 666, 561 cm–1.
HRMS (EI): m/z [M – H]+ calcd for C6H12Br2O: 258.9234;
found: 258.9156.
This work is financially supported by Shanghai Municipal Commit-
tee of Science and Technology (064319022), 111 project (B07023),
the national ‘863’ Project of China (2006AA609Z447 and
2007AA02Z301) and Shanghai Pujian Program (05PJ14035).
References and Notes
Compound 3b: 1H NMR (400 MHz, CDCl3): d = 3.56–3.48
(m, 1 H), 3.42–3.35 (m, 3 H), 3.22 (t, J = 8.0 Hz, 1 H), 2.34
(br, 1 H), 1.90–1.84 (m, 2 H), 1.60–1.48 (m, 4 H). 13C NMR
(100 MHz, CDCl3): d = 70.7, 35.6, 33.7, 32.4, 24.3, 16.4.
Compound 4a: 1H NMR (400 MHz, CDCl3): d = 4.74 (dd,
J = 28.0, 8.0 Hz, 2 H), 3.98–3.92 (m, 1 H), 3.75 (dd,
J = 12.0, 4.0 Hz, 1 H), 3.67 (dd, J = 12.0, 4.0 Hz, 1 H), 3.57
(dd, J = 12.0, 8.0 Hz, 1 H), 3.41 (s, 3 H), 2.75 (br, 1 H), 2.63
(d, J = 4.0 Hz, 2 H), 0.14 (s, 9 H). 13C NMR (100 MHz,
CDCl3): d = 102.6, 96.6, 87.4, 76.7, 72.0, 56.0, 36.4, 22.4,
–0.0(4). IR (neat): 3437, 2958, 2899, 2177, 1420, 1250, 699,
646 cm–1. HRMS (EI): m/z [M – H]+ calcd for C11H21BrO3Si:
307.0443; found: 307.0349.
(1) (a) Piva, O. Tetrahedron Lett. 1992, 33, 2459.
(b) Berkessel, A.; Rollmann, C.; Chamouleau, F.; Labs, S.;
May, O.; Gröger, H. Adv. Synth. Catal. 2007, 349, 2697.
(c) de Jong, R. M.; Tiesinga, J. J. W.; Villa, A.; Tang, L.;
Janssen, D. B.; Dijkstra, B. W. J. Am.Chem. Soc. 2005, 127,
13338.
(2) For reviews, see: (a) Moore, R. E. In Marine Natural
Products, Vol. 1; Scheuer, P. J., Ed.; Academic: New York,
1978, Chap. 2. (b) Fenical, W. In Marine Natural Products,
Vol. 2; Scheuer, P. J., Ed.; Academic: New York, 1980,
174. (c) Barrow, K. D. In Marine Natural Products, Vol. 5;
Scheuer, P. J., Ed.; Academic: New York, 1983, 51.
(3) (a) Righi, G.; Franchini, T.; Bonini, C. Tetrahedron Lett.
1998, 39, 2385. (b) Babudri, F.; Fiandanese, V.; Marchese,
G.; Punzi, A. Tetrahedron 2001, 57, 549. (c) Boukhris, S.;
Souizi, A. Tetrahedron Lett. 2003, 44, 3259.
(4) (a) Sharghi, H.; Eskandari, M. M. Tetrahedron 2003, 59,
8509. (b) Konnaklieva, M. L.; Dahi, M. L.; Turos, E.
Tetrahedron Lett. 1992, 33, 7093. (c) Stewart, C. A.;
Vander Werf, C. A. J. Am. Chem. Soc. 1954, 76, 1259.
(d) Kotsuki, H.; Shimanouchi, T. Tetrahedron Lett. 1996,
37, 1845. (e) Sabitha, G.; Babu, R. S.; Rajkumar, M.; Reddy,
C. S.; Yadav, J. S. Tetrahedron Lett. 2001, 42, 3955.
(f) Pinto, R. M. A.; Salvador, J. A. R.; Roux, C. L.
Tetrahedron 2007, 63, 9221. (g) Das, B.; Krishnaiah, M.;
Venkateswarlu, K. Tetrahedron Lett. 2006, 47, 4457.
(5) (a) Wu, J.; Sun, X.; Sun, W.; Ye, S. Synlett 2006, 2489.
(b) Niknam, K.; Nasehi, T. Tetrahedron 2002, 58, 10259.
(6) Bajwa, J. S.; Anderson, R. C. Tetrahedron Lett. 1991, 32,
3021.
Compound 4b: 1H NMR (400 MHz, CDCl3): d = 4.77–4.68
(m, 2 H), 3.75–3.66 (m, 2 H), 3.49–3.45 (m, 1 H), 3.40 (d,
J = 8.0 Hz, 3 H), 3.35–3.31 (m, 1 H), 2.75 (br, 1 H), 2.61 (d,
J = 8.0 Hz, 2 H), 0.12 (d, J = 8.0 Hz, 9 H). 13C NMR (100
MHz, CDCl3): d = 102.6, 96.7, 87.4, 78.4, 72.2, 56.1, 22.4,
11.0, –0.0(0).
Compound 5a: 1H NMR (400 MHz, CDCl3): d = 3.79–3.72
(m, 2 H), 3.59 (dd, J = 12.0, 4.0 Hz, 1 H), 3.51–3.43 (m, 2
H), 3.35 (dd, J = 12.0, 8.0 Hz, 1 H), 2.76 (br, 2 H), 1.55–1.43
(m, 6 H), 1.40–1.30 (m, 4 H). 13C NMR (100 MHz, CDCl3):
d = 71.3, 71.0, 50.4, 40.4, 34.9, 34.0, 29.3, 29.2, 25.4, 25.3.
Compound 5b: 1H NMR (400 MHz, CDCl3): d = 3.78–3.73
(m, 1 H), 3.57 (dd, J = 8.0, 4.0 Hz, 1 H), 3.50–3.42 (m, 2 H),
3.32 (dd, J = 8.0, 4.0 Hz, 1 H), 3.21–3.17 (m, 1 H), 3.04 (br,
2 H), 1.55–1.39 (m, 6 H), 1.38–1.26 (m, 4 H). 13C NMR (100
MHz, CDCl3): d = 71.3, 70.8, 50.3, 36.4, 34.0, 29.2, 25.5,
25.4, 16.3.
Compound 6a: 1H NMR (400 MHz, CDCl3): d = 3.85–3.79
(m, 2 H), 3.56 (dd, J = 12.0, 4.0 Hz, 1 H), 3.48–3.38 (m, 3
H), 2.14 (d, J = 4.0 Hz, 1 H), 1.61–1.50 (m, 4 H), 1.43–1.32
(m, 6 H), 0.91 (s, 9 H), 0.10 (d, J = 8.0 Hz, 6 H). 13C NMR
(100 MHz, CDCl3): d = 72.4, 71.0, 48.5, 40.6, 35.0, 34.8,
29.5, 25.8, 25.5, 24.7, 18.1, –4.5, –4.6. IR (neat): 3393,
2931, 2857, 1463, 1255, 1099, 837, 777 cm–1.
(7) (a) Ranu, B. C.; Banerjee, S. J. Org. Chem. 2005, 70, 4517.
(b) Ranu, B. C.; Adak, L.; Banerjee, S. Can. J. Chem. 2007,
85, 366.
(8) General Procedure
To the solution of epoxide (5 mmol) in CH2Cl2 (8 mL) was
added active MgX2·THF (2.0 equiv, M = 1.78 mol/L) at r.t.
The reaction was stirred at the same temperature for 1 min
and then quenched with sat. aq NH4Cl. The solvent was
removed under vacuum. and the residue was extracted with
EtOAc. The combined organic layer was washed with H2O
and brine, dried over anhyd Na2SO4, and concentrated under
reduced pressure. Purification of the residue was by
chromatography on SiO2 to give the product.
Compound 6b: 1H NMR (400 MHz, CDCl3): d = 3.85–3.80
(m, 1 H), 3.56–3.48 (m, 1 H), 3.46–3.38 (m, 3 H), 3.25 (dd,
J = 12.0, 8.0 Hz, 1 H), 2.03 (d, J = 8.0 Hz, 1 H), 1.66–1.53
(m, 4 H), 1.46–1.31 (m, 6 H), 0.91 (s, 9 H), 0.10 (d, J = 4.0
Hz, 6 H). 13C NMR (100 MHz, CDCl3): d = 72.4, 70.9, 48.5,
36.5, 34.8, 29.5, 25.8, 25.6, 24.7, 18.1, 16.6, –4.4, –4.6.
(10) Eisch, J. J.; Liu, Z. R.; Zheng, G. X. J. Org. Chem. 1992, 57,
5140.
(9) Spectral Data of Compounds 1a–c, 2a,b, 3c, 7a, 7a¢, 7b,
7b¢ matched in all respects with reported data.
Synlett 2009, No. 9, 1511–1513 © Thieme Stuttgart · New York